Ensysce Biosciences (ENSC) Earnings Date & Reports

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ENSC is expected to report earnings to rise 36.54% to -70 cents per share on August 19

Ensysce Biosciences ENSC Stock Earnings Reports

Q2'26

Est.

$-0.71

Q1'26

Beat

by $0.30

Q4'25

Beat

by $0.33

Q3'25

Missed

by $0.22

Q2'25

Beat

by $0.30

The last earnings report on May 18 showed earnings per share of -51 cents, beating the estimate of -81 cents. With 360.59K shares outstanding, the current market capitalization sits at 4.24M.

View a ticker or compare two or three

Compare

ENSC

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ENSC